Leading the Way in Life Science Technologies

GEN Exclusives

More »

Columns

More »

For full access to this article login to GEN Select now.

Apr 15, 2014 (Vol. 34, No. 8)

Spotty Progress on Single-Use Standards

Vendors Work to Standardize Protocols but Resist End Users’ Calls for Interoperability

  • Intellectual property issues and lifecycle-level business decisions seriously limit inter-vendor interoperability for single-use bioprocessing equipment. Nevertheless, standards are evolving through the collaboration between vendor ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »